JB Chemicals and Pharmaceuticals Ltd recalls Cetirizine Hydrochloride Tablets USP 10 mg
FDA Class III
FDA classified this recall as Class III: the product is unlikely to cause health problems but breaks the agency's rules (a labeling mistake, for example).
- Hazard
- Tablet/Capsules Imprinted with Wrong ID
- Products
-
- Cetirizine Hydrochloride Tablets USP 10 mg
- Where it was sold
-
U.S. Nationwide
Nationwide
- Units affected
- 13,440 bottles
- About this recall
- Cetirizine Hydrochloride Tablets USP 10 mg, 500 Tablets bottles, Manufactured by: Unique Pharmaceuticals Labs, (A Div. of J.B. Chemicals & Pharmaceuticals, Ltd.), Mumbai 400 030, India. Distributed by: Rising Pharma Holdings, Inc., East Brunswick, NJ 08816, NDC 16571-402-50